AAAAAA
Results: 1-25/102
Authors:
SIU LL
BANERJEE D
KHURANA RJ
PAN X
PFLUEGER R
TANNOCK IF
MOORE MJ
Citation: Ll. Siu et al., THE PROGNOSTIC ROLE OF P53, METALLOTHIONEIN, P-GLYCOPROTEIN, AND MIB-1 IN MUSCLE-INVASIVE UROTHELIAL TRANSITIONAL-CELL CARCINOMA, Clinical cancer research, 4(3), 1998, pp. 559-565
Authors:
SIU LL
BANERJEE D
KHURANA RJ
PAN X
PFLUEGER R
TANNOCK IF
MOORE MJ
Citation: Ll. Siu et al., THE PROGNOSTIC ROLE OF P53, METALLOTHIONEIN, P-GLYCOPROTEIN, AND MIB-1 IN MUSCLE-INVASIVE UROTHELIAL TRANSITIONAL-CELL CARCINOMA, Clinical cancer research, 4(3), 1998, pp. 559-565
Authors:
MOORE MJ
Citation: Mj. Moore, POWER AND ENERGY, Proceedings of the Institution of Mechanical Engineers. Part A, Journal of power and energy, 212(A4), 1998, pp. 1-1
Authors:
MOORE MJ
Citation: Mj. Moore, A LITTLE LEARNING, Proceedings of the Institution of Mechanical Engineers. Part A, Journal of power and energy, 212(A3), 1998, pp. 1-1
Authors:
MOORE MJ
Citation: Mj. Moore, SEEING VISIONS, Proceedings of the Institution of Mechanical Engineers. Part A, Journal of power and energy, 212(A2), 1998, pp. 1-1
Authors:
MOORE MJ
Citation: Mj. Moore, THE POWER OF THE PRESS, Proceedings of the Institution of Mechanical Engineers. Part A, Journal of power and energy, 212(1), 1998, pp. 1-1
Authors:
SIU LL
MOORE MJ
Citation: Ll. Siu et Mj. Moore, USE OF MESNA TO PREVENT IFOSFAMIDE-INDUCED UROTOXICITY, Supportive care in cancer, 6(2), 1998, pp. 144-154
Authors:
MOORE MJ
TANNOCK I
WINQUIST E
TOLCHER A
BENNETT K
SEYMOUR L
Citation: Mj. Moore et al., GEMCITABINE(G)- AN ACTIVE REGIMEN IN ADVANCED CELL-CARCINOMA (TCC) - AN NCIC STUDY( CISPLATIN (C) ), Annals of oncology, 9, 1998, pp. 270-270
Authors:
MICHAEL M
OZA A
EGORIN MJ
PATNAIK A
FIRBY P
SIU LL
LITCHMAN M
MOORE MJ
Citation: M. Michael et al., PHARMACOKINETIC (PK) AND PHARMACODYNAMIC (PD) ANALYSIS OF A PHASE-I STUDY OF TAXOL((R))(T), CARBOPLATIN (C) WITH P-GLYCOPROTEIN (P-GP) MODULATOR PSC-833 (PSC), Annals of oncology, 9, 1998, pp. 621-621
Authors:
MICHAEL M
MOORE MJ
Citation: M. Michael et Mj. Moore, ASSESSING THE IMPACT OF CHEMOTHERAPY ON TUMOR-RELATED SYMPTOMS IN ADVANCED COLORECTAL-CANCER, Oncology, 12(8), 1998, pp. 121-128
Authors:
BLOOMFIELD DJ
KRAHN MD
NEOGI T
PANZARELLA T
SMITH TJ
WARDE P
WILLAN AR
ERNST S
MOORE MJ
NEVILLE A
TANNOCK IF
Citation: Dj. Bloomfield et al., ECONOMIC-EVALUATION OF CHEMOTHERAPY WITH MITOXANTRONE PLUS PREDNISONEFOR SYMPTOMATIC HORMONE-RESISTANT PROSTATE-CANCER - BASED ON A CANADIAN RANDOMIZED TRIAL WITH PALLIATIVE END-POINTS, Journal of clinical oncology, 16(6), 1998, pp. 2272-2279
Authors:
SIU LL
OZA AM
EISENHAUER EA
FIRBY PS
THIESSEN JJ
MICHAEL M
WAINMAN N
MANZO J
FELD R
GOLDBERG RA
MOORE MJ
Citation: Ll. Siu et al., PHASE-I AND PHARMACOLOGICAL STUDY OF 9-AMINOCAMPTOTHECIN COLLOIDAL DISPERSION FORMULATION GIVEN AS A 24-HOUR CONTINUOUS-INFUSION WEEKLY TIMES 4 EVERY 5 WEEKS, Journal of clinical oncology, 16(3), 1998, pp. 1122-1130
Authors:
MOORE MJ
FELD R
HEDLEY D
OZA A
SIU LL
Citation: Mj. Moore et al., A PHASE-II STUDY OF TEMOZOLOMIDE IN ADVANCED UNTREATED PANCREATIC-CANCER, Investigational new drugs, 16(1), 1998, pp. 77-79
Authors:
GLEAVE ME
ELHILALI M
FRADET Y
DAVIS I
VENNER P
SAAD F
KLOTZ LH
MOORE MJ
PATON V
BAJAMONDE A
Citation: Me. Gleave et al., INTERFERON GAMMA-1B COMPARED WITH PLACEBO IN METASTATIC RENAL-CELL CARCINOMA, The New England journal of medicine, 338(18), 1998, pp. 1265-1271
Authors:
CZAYKOWSKI PM
MOORE MJ
TANNOCK IF
Citation: Pm. Czaykowski et al., HIGH-RISE OF VASCULAR EVENTS IN PATIENTS WITH UROTHELIAL TRANSITIONAL-CELL CARCINOMA TREATED WITH CISPLATIN-BASED CHEMOTHERAPY, The Journal of urology, 160(6), 1998, pp. 2021-2024
Authors:
MOORE MJ
RIENZO BA
Citation: Mj. Moore et Ba. Rienzo, SEXUAL HARASSMENT POLICIES IN FLORIDA SCHOOL DISTRICTS, Journal of school health, 68(6), 1998, pp. 237-242
ROLE OF GLUTATHIONE S-TRANSFERASES IN THE RESISTANCE OF HUMAN COLON-CANCER CELL-LINES TO DOXORUBICIN
Authors:
BEAUMONT PO
MOORE MJ
AHMAD K
PAYNE MM
LEE CJ
RIDDICK DS
Citation: Po. Beaumont et al., ROLE OF GLUTATHIONE S-TRANSFERASES IN THE RESISTANCE OF HUMAN COLON-CANCER CELL-LINES TO DOXORUBICIN, Cancer research, 58(5), 1998, pp. 947-955
Authors:
MICHAEL M
TANNOCK IF
CZAYKOWSKI PM
MOORE MJ
Citation: M. Michael et al., ADJUVANT CHEMOTHERAPY FOR HIGH-RISK UROTHELIAL TRANSITIONAL-CELL CARCINOMA - THE PRINCESS-MARGARET-HOSPITAL EXPERIENCE, British Journal of Urology, 82(3), 1998, pp. 366-372
Authors:
MOORE MJ
Citation: Mj. Moore, IS YOUR PULMONARY-ARTERY CATHETER SHEDDING - IN REPLY, Anesthesiology, 89(2), 1998, pp. 544-544
Authors:
MOORE MJ
Citation: Mj. Moore, A CARBON-DIOXIDE CAUSERIE, Proceedings of the Institution of Mechanical Engineers. Part A, Journal of power and energy, 211(6), 1997, pp. 1-1
Authors:
MOORE MJ
Citation: Mj. Moore, CONFERENCE CALLS, Proceedings of the Institution of Mechanical Engineers. Part A, Journal of power and energy, 211(5), 1997, pp. 1-1
Authors:
MOORE MJ
Citation: Mj. Moore, WHATS NEW, Proceedings of the Institution of Mechanical Engineers. Part A, Journal of power and energy, 211(4), 1997, pp. 289-289
Authors:
MOORE MJ
Citation: Mj. Moore, SPECIAL ISSUE ON TURBOMACHINERY, Proceedings of the Institution of Mechanical Engineers. Part A, Journal of power and energy, 211(3), 1997, pp. 195-195
Authors:
MOORE MJ
Citation: Mj. Moore, THINGS CAN ONLY GET BETTER, Proceedings of the Institution of Mechanical Engineers. Part A, Journal of power and energy, 211(2), 1997, pp. 111-111
Authors:
MOORE MJ
Citation: Mj. Moore, THE COMPETITIVE MARKET FOR ENERGY 1998 AND BEYOND, Proceedings of the Institution of Mechanical Engineers. Part A, Journal of power and energy, 211(2), 1997, pp. 193-193